Pharmacoflash 7 : Immunosuppressive drugs (1)

15:00 • 740 • Kidney function does not differ across tacrolimus C0/dose metabolizer phenotypes under AUC-guided therapeutic drug monitoring > A. Amar Levens 15:06 • 679 • Absence of bioequivalence for generic formulations of mycophenolate mofetil if combined with proton pump inhibitor > K. Kim Gombert-Handoko 15:12 • 409 • Chronic Kidney Disease After Lung Transplantation: Impact of Tacrolimus Exposure and Clinical Complications Post-Transplantation > D. Dennis A. HESSELINK 15:18 • 327 • Discovery of novel CYP3A5 biomarker candidates by non-targeted metabolomics in Japanese general population and patient cohorts > N. Nao Yamagishi 15:24 • 144 • Implementation of pharmacogenetics in kidney transplantation: a national survey among nephrologists > D. Dorian CHASTAGNER 15:30 • 117 • A Unified Machine Learning Framework for Next-Visit Tacrolimus Concentration Prediction and Model-Informed Dose Individualization in Renal Transplant Recipients > Z-L. Zhao-Lin Chen 15:36 • 67 • Early Supratherapeutic Tacrolimus Exposure and Early Infection Risk After Lung Transplantation: Evidence of a Quantitative Exposure–Response Trend > Y. Yongwu CHEN